Alzheimer’s play­er AC Im­mune taps IPO for $58M raise, sees shares soar

Swiss biotech AC Im­mune fol­lowed through on its IPO $ACIU to­day, pric­ing at $11 a share. That’s the low end of the range, but …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.